Reaction Details Report a problem with these data
Target
Uracil nucleotide/cysteinyl leukotriene receptor
Ligand
BDBM646551
Substrate
n/a
Meas. Tech.
GPR17 cAMP Assay Protocol
IC50
13.0±n/a nM
Citation
 GALLEY, G; GOBBI, L; GUBA, W; MAZUNIN, D; PINARD, E; RICCI, A PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES US Patent  US20240025883 Publication Date 1/25/2024 
Target
Name:
Uracil nucleotide/cysteinyl leukotriene receptor
Synonyms:
GPR17 | GPR17_HUMAN
Type:
PROTEIN
Mol. Mass.:
41013.71
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1353471
Residue:
367
Sequence:
MSKRSWWAGSRKPPREMLKLSGSDSSQSMNGLEVAPPGLITNFSLATAEQCGQETPLENMLFASFYLLDFILALVGNTLALWLFIRDHKSGTPANVFLMHLAVADLSCVLVLPTRLVYHFSGNHWPFGEIACRLTGFLFYLNMYASIYFLTCISADRFLAIVHPVKSLKLRRPLYAHLACAFLWVVVAVAMAPLLVSPQTVQTNHTVVCLQLYREKASHHALVSLAVAFTFPFITTVTCYLLIIRSLRQGLRVEKRLKTKAVRMIAIVLAIFLVCFVPYHVNRSVYVLHYRSHGASCATQRILALANRITSCLTSLNGALDPIMYFFVAEKFRHALCNLLCGKRLKGPPPSFEGKTNESSLSAKSEL
  
Inhibitor
Name:
BDBM646551
Synonyms:
N-(5-allyl-4,6-dimethoxy- pyrimidin-2-yl)-6-chloro-1H- indole-3-sulfonamide | US20240025883, Example 56
Type:
Small organic molecule
Emp. Form.:
C17H17ClN4O4S
Mol. Mass.:
408.859
SMILES:
COc1nc(NS(=O)(=O)c2c[nH]c3cc(Cl)ccc23)nc(OC)c1CC=C
Structure:
Search PDB for entries with ligand similarity: